TuHURA Biosciences (HURA) Cash & Equivalents (2010 - 2026)
TuHURA Biosciences (HURA) posted Cash & Equivalents of $1 million for Q2 2026, down 88.3% from $8.51 million a year earlier and down 84.1% from the prior quarter.
Powered by 
Analysis
TuHURA Biosciences (HURA) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, TuHURA Biosciences' Cash & Equivalents came in at $3.62 million, down 71.4% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of 8.6% (FY2020 to FY2025).
- In prior years, TuHURA Biosciences' Cash & Equivalents was $12.66 million in FY2024 (+245.3%), $3.67 million in FY2023, $11.78 million in FY2022 (+11.8%) and $10.54 million in FY2021 (+340.5%).
- The Q2 2026 figure stands as the lowest quarterly Cash & Equivalents since Q4 2012.
- On a year-over-year basis, Cash & Equivalents increased in two of the last five quarters, with growth averaging 17.0%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $6.3 million (Q1 2026), $3.62 million (Q4 2025) and $2.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | TuHURA Biosciences | 35.65 Mn | 35.65 Mn | - | 1.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 Mn |
| Mar 31, 2026 | 6.30 Mn |
| Dec 31, 2025 | 3.62 Mn |
| Sep 30, 2025 | 2.70 Mn |
| Jun 30, 2025 | 8.51 Mn |
| Mar 31, 2025 | 6.22 Mn |
| Dec 31, 2024 | 12.66 Mn |
| Sep 30, 2024 | 3.02 Mn |
| Jun 30, 2024 | 4.91 Mn |
| Mar 31, 2024 | 6.35 Mn |
| Dec 31, 2023 | 3.67 Mn |
| Sep 30, 2023 | 216,000.00 |
| Jun 30, 2023 | 1.54 Mn |
| Mar 31, 2023 | 3.05 Mn |
| Dec 31, 2022 | 4.87 Mn |
| Sep 30, 2022 | 7.09 Mn |
| Jun 30, 2022 | 11.78 Mn |
| Mar 31, 2022 | 8.84 Mn |
| Dec 31, 2021 | 14.06 Mn |
| Sep 30, 2021 | 19.34 Mn |
API Access
TuHURA Biosciences Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=HURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "HURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=HURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();